Suppr超能文献

锝标记的肿瘤相关糖蛋白72结合肽G3 - 15和T3 - 15

Tc-Labeled tumor-associated glycoprotein 72 binding peptides G3-15 and T3-15

作者信息

Chopra Arvind

机构信息

National Center for Biotechnology Information, NLM, Bethesda, MD 20894

Abstract

The tumor-associated glycoprotein 72 (TAG-72) is a high molecular weight mucigenous protein that is found mainly in the extracellular matrix of neoplastic tumors (1). This glycoprotein is usually not expressed in normal tissues but is overexpressed in the tumors of several cancers, such as those of the colon and rectum (colorectal cancer), stomach, pancreas, ovaries, prostate, lung, breast, etc. Therefore, TAG-72 is considered to have much theranostic value (useful for the diagnosis and/or therapy of a disease) because it can be used for antigen-directed surgical resection of cancerous tumors with radiolabeled anti-TAG-72 monoclonal antibodies (mAb) (1). In addition, the detection or absence of TAG-72 expression in colorectal cancer tumors was shown to have prognostic value because individuals who had complete removal of tumors with surgery guided by mouse anti-Tag-72 mAb were shown to have a long-term survival advantage compared to patients who had an incomplete removal of the lesions (2). However, the main limitation of using radiolabeled antibodies (Ab) or their fragments to detect and treat malignant tumors is the long circulation half-life of these molecules and the development of human anti-mouse antibodies in the patients (3). In comparison, synthetic anti-tumor peptides that can be used for the noninvasive imaging and therapy of cancers show rapid clearance from circulation and non-target tissue, have more access and deeper penetration into the lesions, and may not be immunogenic (3-5). Recently, the peptides GGVSCMQTSPVCENNL (A2-6) and NPGTCKDKWEICLLNGG (A3-10) were identified from a phase-display peptide library (f88-4/cys6) against TAG-72 and labeled with Tc to generate [Tc]-A2-6 and [Tc]-A3-10 (4). The labeled peptides were then evaluated in mice for the detection of LS-174T cell xenograft tumors that overexpress the TAG-72 antigen. In another study, two new peptides, FRERCDKHPQKCTKFL (G3-15) and DPRHCQKRVLPCPAWL (T3-15), which had a high affinity for the TAG-72 antigen, were identified when a modified procedure (from that used to purify the A2-6 and A3-10 peptides) was used to purify peptides from the f88-4/cys6 phage library (3). These peptides were then labeled with Tc to obtain [Tc]-G3-15 and [Tc]-T3-15, and the labeled compounds were tested for the detection of LS-174T cell xenograft tumors in mice. This chapter describes the results obtained with [Tc]-G3-15 and [Tc]-T3-15. Studies performed with [Tc]-A2-6 and [Tc]-A3-10 are described in a separate chapter of MICAD (www.micad.nih.gov) (6).

摘要

肿瘤相关糖蛋白72(TAG - 72)是一种高分子量的粘蛋白,主要存在于肿瘤的细胞外基质中(1)。这种糖蛋白通常在正常组织中不表达,但在多种癌症的肿瘤中过度表达,如结肠和直肠(结直肠癌)、胃、胰腺、卵巢、前列腺、肺、乳腺等部位的肿瘤。因此,TAG - 72被认为具有很大的诊疗价值(对疾病的诊断和/或治疗有用),因为它可用于用放射性标记的抗TAG - 72单克隆抗体(mAb)进行癌性肿瘤的抗原导向手术切除(1)。此外,结直肠癌肿瘤中TAG - 72表达的检测或缺失具有预后价值,因为与病变切除不完全的患者相比,在小鼠抗Tag - 72 mAb引导下通过手术完全切除肿瘤的个体显示出长期生存优势(2)。然而,使用放射性标记抗体(Ab)或其片段检测和治疗恶性肿瘤的主要局限性在于这些分子的长循环半衰期以及患者体内人抗鼠抗体的产生(3)。相比之下,可用于癌症无创成像和治疗的合成抗肿瘤肽从循环和非靶组织中清除迅速,对病变有更多的接触和更深的渗透,并且可能不具有免疫原性(3 - 5)。最近,从针对TAG - 72的噬菌体展示肽库(f88 - 4/cys6)中鉴定出肽GGVSCMQTSPVCENNL(A2 - 6)和NPGTCKDKWEICLLNGG(A3 - 10),并用锝标记以生成[Tc]-A2 - 6和[Tc]-A3 - 10(4)。然后在小鼠中评估标记的肽用于检测过表达TAG - 72抗原的LS - 174T细胞异种移植肿瘤。在另一项研究中,当使用改良程序(与用于纯化A2 - 6和A3 - 10肽的程序不同)从f88 - 4/cys6噬菌体库中纯化肽时,鉴定出了对TAG - 72抗原有高亲和力的两种新肽FRERCDKHPQKCTKFL(G3 - 15)和DPRHCQKRVLPCPAWL(T3 - 15)(3)。然后用锝标记这些肽以获得[Tc]-G3 - 15和[Tc]-T3 - 15,并测试标记的化合物用于检测小鼠中的LS - 174T细胞异种移植肿瘤。本章描述了用[Tc]-G3 - 15和[Tc]-T3 - 15获得的结果。用[Tc]-A2 - 6和[Tc]-A3 - 10进行的研究在MICAD的单独一章中描述(www.micad.nih.gov)(6)。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验